FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
Key Details
- 1FDA has approved the Targeted Real-Time Early Warning System for sepsis from researchers at Johns Hopkins, commercialized by Bayesian Health.
- 2The AI analyzes electronic health records to identify sepsis earlier than doctors traditionally can—often by 2 to 48 hours.
- 3System deployment in multiple hospitals reduced sepsis mortality rates by 18% and shortened hospital stays.
- 4Sepsis leads to over 250,000 deaths annually in the US and accounts for one in three in-hospital deaths.
- 5FDA clearance enables hospitals to bill Medicare/Medicaid under the New Technology Add-on Payment program.
- 6The solution demonstrates robust clinical AI integration with real-world hospital data for actionable guidance.
Why It Matters
The FDA's clearance of this early sepsis warning system marks a significant milestone for clinical AI adoption, demonstrating real-world impact on patient outcomes. It highlights how machine learning can augment clinical vigilance and potentially become part of standard hospital care, informing future radiology-AI solutions.
Source
EurekAlert
Related News
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
Mayo Clinic Showcases Imaging AI and Early Cancer Detection Advances at ASCO 2026
Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
•EurekAlert
ACM Honors 3D Generative AI and NeRF Innovators With Technical Awards
ACM recognized researchers for breakthroughs in wireless standards, artificial intelligence, and 3D generative AI, including major advances in neural radiance fields impacting computer vision and medical imaging.